Objective: To explore the expression of Th1/Th2 cytokines gene in human gliomas and its role in the genesis and development of human gliomas.Methods: Using IL-2 and IFNγ as Th1 type cytokines, IL-4, IL-6 and IL-10 as...Objective: To explore the expression of Th1/Th2 cytokines gene in human gliomas and its role in the genesis and development of human gliomas.Methods: Using IL-2 and IFNγ as Th1 type cytokines, IL-4, IL-6 and IL-10 as Th2 type cytokines, the biological activity of cytokines in the supernatant of glioma cell lines was assayed by ELISA method, and the gene expression of Th1/Th2 cytokines in human glioma cells, glioma infiltrating lymphocytes and glioma cell lines were detected by RT-PCR.Results: There was predominant expression of Th2 type cytokines in human glioma cells, glioma infiltrating lymphocytes and glioma cell lines, but there was no such expression in normal brain tissues.Conclusion: It suggested that there is a relationship between the Th2 type cytokines expression in human gliomas and the immunosupressive status of human glioma patients. The predominant expression of Th2 type cytokines may play an important role in the genesis and development of human gliomas. Key words glioma - Th1/Th2 - gene expression - RT-PCR This project was supported by a grant from National Natural Sciences foundation of China (No. 30271335).展开更多
In this paper, we used SVM method to detect P300 signal. Before training a classification parameter for the SVM, several preprocessing operations were applied to the data including filtering, downsampling, single tria...In this paper, we used SVM method to detect P300 signal. Before training a classification parameter for the SVM, several preprocessing operations were applied to the data including filtering, downsampling, single trial extraction, windsorizing, electrode selection et al. With the SVM algorithm, the classification accuracy could be up to above 80%. In some cases, the accuracy could reach 100%. It is suitable to use SVM for P300 EEG recognition in the P300-based brain-computer interface (BCI) system. Our further work will include the improvement to yield higher classification accuracy using fewer trials.展开更多
基金This project was supported by a grant from National Natural Sciences foundation of China(No.30271335).
文摘Objective: To explore the expression of Th1/Th2 cytokines gene in human gliomas and its role in the genesis and development of human gliomas.Methods: Using IL-2 and IFNγ as Th1 type cytokines, IL-4, IL-6 and IL-10 as Th2 type cytokines, the biological activity of cytokines in the supernatant of glioma cell lines was assayed by ELISA method, and the gene expression of Th1/Th2 cytokines in human glioma cells, glioma infiltrating lymphocytes and glioma cell lines were detected by RT-PCR.Results: There was predominant expression of Th2 type cytokines in human glioma cells, glioma infiltrating lymphocytes and glioma cell lines, but there was no such expression in normal brain tissues.Conclusion: It suggested that there is a relationship between the Th2 type cytokines expression in human gliomas and the immunosupressive status of human glioma patients. The predominant expression of Th2 type cytokines may play an important role in the genesis and development of human gliomas. Key words glioma - Th1/Th2 - gene expression - RT-PCR This project was supported by a grant from National Natural Sciences foundation of China (No. 30271335).
基金Natural Science Foundation of Shandong Provincegrant number:Y2007G31
文摘In this paper, we used SVM method to detect P300 signal. Before training a classification parameter for the SVM, several preprocessing operations were applied to the data including filtering, downsampling, single trial extraction, windsorizing, electrode selection et al. With the SVM algorithm, the classification accuracy could be up to above 80%. In some cases, the accuracy could reach 100%. It is suitable to use SVM for P300 EEG recognition in the P300-based brain-computer interface (BCI) system. Our further work will include the improvement to yield higher classification accuracy using fewer trials.